The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.
Molecularly targeted nanocarriers deliver the cytolytic peptide melittin specifically to tumor cells in mice, reducing tumor growth
Open accessAbstract
The in vivo application of cytolytic peptides for cancer therapeutics is hampered by toxicity, nonspecificity, and degradation. We previously developed a specific strategy to synthesize a nanoscale delivery vehicle for cytolytic peptides by incorporating the nonspecific amphipathic cytolytic peptide melittin into the outer lipid monolayer of a perfluorocarbon nanoparticle. Here, we have demonstrated that the favorable pharmacokinetics of this nanocarrier allows accumulation of melittin in murine tumors in vivo and a dramatic reduction in tumor growth without any apparent signs of toxicity. Furthermore, direct assays demonstrated that molecularly targeted nanocarriers selectively delivered melittin to multiple tumor targets, including endothelial and cancer cells, through a hemifusion mechanism. In cells, this hemifusion and transfer process did not disrupt the surface membrane but did trigger apoptosis and in animals caused regression of precancerous dysplastic lesions. Collectively, these data suggest that the ability to restrain the wide-spectrum lytic potential of a potent cytolytic peptide in a nanovehicle, combined with the flexibility of passive or active molecular targeting, represents an innovative molecular design for chemotherapy with broad-spectrum cytolytic peptides for the treatment of cancer at multiple stages.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
Hancock, R. E. W., & Sahl, H.-G. (2006) · Nature Biotechnology · doi:10.1038/nbt1267 · Cited by 4,208
Requirement of Vascular Integrin α v β 3 for Angiogenesis
Brooks, P. C., Clark, R. A. F., & Cheresh, D. A. (1994) · Science · doi:10.1126/science.7512751 · Cited by 3,020
The effect of particle design on cellular internalization pathways
Gratton, S. E. A., Ropp, P. A., Pohlhaus, P. D., Luft, J. C., Madden, V. J., Napier, M. E., & DeSimone, J. M. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801763105 · Cited by 2,918
Studies on anticancer activities of antimicrobial peptides
Hoskin, D. W., & Ramamoorthy, A. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2007.11.008 · Cited by 1,296
Certo, M., Moore, V. D. G., Nishino, M., Wei, G., Korsmeyer, S., Armstrong, S. A., & Letai, A. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.027 · Cited by 1,288
Desai, N., Trieu, V., Yao, Z., Louie, L., Ci, S., Yang, A., Tao, C., De, T., Beals, B., Dykes, D., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1634 · Cited by 1,175
Barrel-Stave Model or Toroidal Model? A Case Study on Melittin Pores
Yang, L., Harroun, T. A., Weiss, T. M., Ding, L., & Huang, H. W. (2001) · Biophysical Journal · doi:10.1016/s0006-3495(01)75802-x · Cited by 1,114
Brodie, S. E. (1996) · Survey of Ophthalmology · doi:10.1016/s0039-6257(96)80075-0 · Cited by 745
αv Integrins as receptors for tumor targeting by circulating ligands
Pasqualini, R., Koivunen, E., & Ruoslahti, E. (1997) · Nature Biotechnology · doi:10.1038/nbt0697-542 · Cited by 744
Uptake and Intracellular Fate of Surface-Modified Gold Nanoparticles
Nativo, P., Prior, I. A., & Brust, M. (2008) · ACS Nano · doi:10.1021/nn800330a · Cited by 659
In vivo imaging platform for tracking immunotherapeutic cells
Ahrens, E. T., Flores, R., Xu, H., & Morel, P. A. (2005) · Nature Biotechnology · doi:10.1038/nbt1121 · Cited by 620
Antimicrobial peptides: an overview of a promising class of therapeutics
Giuliani, A., Pirri, G., & Nicoletto, S. (2007) · Open Life Sciences · doi:10.2478/s11535-007-0010-5 · Cited by 606
Structure and Functions of Channel-Forming Peptides: Magainins, Cecropins, Melittin and Alamethicin
Bechinger, B. (1997) · Journal of Membrane Biology · doi:10.1007/s002329900201 · Cited by 602
Detergent-like actions of linear amphipathic cationic antimicrobial peptides
Bechinger, B., & Lohner, K. (2006) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.07.001 · Cited by 593
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
Hamzah, J., Jugold, M., Kiessling, F., Rigby, P., Manzur, M., Marti, H. H., Rabie, T., Kaden, S., Gröne, H.-J., Hämmerling, G. J., et al. (2008) · Nature · doi:10.1038/nature06868 · Cited by 564
Li, Y. C., Park, M. J., Ye, S.-K., Kim, C.-W., & Kim, Y.-N. (2006) · The American Journal of Pathology · doi:10.2353/ajpath.2006.050959 · Cited by 536
Deng, J., Carlson, N., Takeyama, K., Dal Cin, P., Shipp, M., & Letai, A. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.07.001 · Cited by 513
Host defense peptides as new weapons in cancer treatment
Papo, N., & Shai, Y. (2005) · CMLS Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4560-2 · Cited by 501
Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis
Murphy, E. A., Majeti, B. K., Barnes, L. A., Makale, M., Weis, S. M., Lutu-Fuga, K., Wrasidlo, W., & Cheresh, D. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803728105 · Cited by 455
BAX-dependent transport of cytochrome c reconstituted in pure liposomes
Saito, M., Korsmeyer, S. J., & Schlesinger, P. H. (2000) · Nature Cell Biology · doi:10.1038/35019596 · Cited by 446
Self-citationDetermination of Doxorubicin Levels in Whole Tumor and Tumor Nuclei in Murine Breast Cancer Tumors
Laginha, K. M., Verwoert, S., Charrois, G. J. R., & Allen, T. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0343 · Cited by 441
Emulsions and emulsion stability
(1996) · Choice Reviews Online · doi:10.5860/choice.34-1554 · Cited by 396
Winter, P. M., Neubauer, A. M., Caruthers, S. D., Harris, T. D., Robertson, J. D., Williams, T. A., Schmieder, A. H., Hu, G., Allen, J. S., Lacy, E. K., et al. (2006) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000235724.11299.76 · Cited by 379
Self-citationWinter, P. M., Caruthers, S. D., Kassner, A., Harris, T. D., Chinen, L. K., Allen, J. S., Lacy, E. K., Zhang, H., Robertson, J. D., Wickline, S. A., et al. (2003) · PubMed · Cited by 371
Self-citationPartlow, K. C., Chen, J., Brant, J. A., Neubauer, A. M., Meyerrose, T. E., Creer, M. H., Nolta, J. A., Caruthers, S. D., Lanza, G. M., & Wicldine, S. A. (2007) · The FASEB Journal · doi:10.1096/fj.06-6505com · Cited by 306
Self-citationProgressive squamous epithelial neoplasia in K14-human papillomavirus type 16 transgenic mice
Arbeit, J. M., Münger, K., Howley, P. M., & Hanahan, D. (1994) · Journal of Virology · doi:10.1128/jvi.68.7.4358-4368.1994 · Cited by 305
Self-citationEnergetics of Pore Formation Induced by Membrane Active Peptides
Lee, M.-T., Chen, F.-Y., & Huang, H. W. (2004) · Biochemistry · doi:10.1021/bi036153r · Cited by 299
Phase I and Correlative Biology Study of Cilengitide in Patients With Recurrent Malignant Glioma
Nabors, L. B., Mikkelsen, T., Rosenfeld, S. S., Hochberg, F., Akella, N. S., Fisher, J. D., Cloud, G. A., Zhang, Y., Carson, K., Wittemer, S. M., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.6514 · Cited by 290
Mechanism and kinetics of pore formation in membranes by water-soluble amphipathic peptides
Lee, M.-T., Hung, W.-C., Chen, F.-Y., & Huang, H. W. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710625105 · Cited by 282
Kinetics and mechanism of hemolysis induced by melittin and by a synthetic melittin analogue
DeGrado, W. F., Musso, G. F., Lieber, M., Kaiser, E. T., & Kézdy, F. J. (1982) · Biophysical Journal · doi:10.1016/s0006-3495(82)84681-x · Cited by 266
Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticles
Schmieder, A. H., Winter, P. M., Caruthers, S. D., Harris, T. D., Williams, T. A., Allen, J. S., Lacy, E. K., Zhang, H., Scott, M. J., Hu, G., et al. (2005) · Magnetic Resonance in Medicine · doi:10.1002/mrm.20391 · Cited by 246
Self-citationECM Remodeling Regulates Angiogenesis: Endothelial Integrins Look for New Ligands
Stupack, D. G., & Cheresh, D. A. (2002) · Science's STKE · doi:10.1126/stke.2002.119.pe7 · Cited by 215
Kumar, M. N. V. R., Sameti, M., Mohapatra, S. S., Kong, X., Lockey, R. F., Bakowsky, U., Lindenblatt, G., Schmidt, C. H., & Lehr, C.-M. (2004) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2004.120 · Cited by 198
Cianfrocca, M. E., Kimmel, K. A., Gallo, J., Cardoso, T., Brown, M. M., Hudes, G., Lewis, N., Weiner, L., Lam, G. N., Brown, S. C., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603171 · Cited by 184
Pharmacokinetics and Side Effects of Perfluorocarbon-Based Blood Substitutes
Flaim, S. F. (1994) · Artificial Cells, Blood Substitutes, and Biotechnology · doi:10.3109/10731199409138801 · Cited by 174
Antimicrobial peptides: therapeutic potential
Zhang, L., & Falla, T. J. (2006) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.7.6.653 · Cited by 159
Lateral Diffusion in Lipid Membranes through Collective Flows
Falck, E., Róg, T., Karttunen, M., & Vattulainen, I. (2008) · Journal of the American Chemical Society · doi:10.1021/ja7103558 · Cited by 159
Antitumor activity of magainin analogues against human lung cancer cell lines.
Ohsaki, Y., Gazdar, A. F., Chen, H. C., & Johnson, B. (1992) · PubMed · Cited by 157
McNeel, D. G., Eickhoff, J. C., Lee, F. T., King, D. M., Alberti, D. B., Thomas, J. P., Friedl, A., Kolesar, J., Marnocha, R., Volkman, J., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0262 · Cited by 156
Effect of Blood Collection Technique in Mice on Clinical Pathology Parameters
Schnell, M. A., Hardy, C. L., Hawley, M., et al. (2002) · Human Gene Therapy · doi:10.1089/10430340152712700 · Cited by 148
Mullamitha, S., Ton, N. C., Parker, G. J. M., Jackson, A., Julyan, P. J., Roberts, C., Buonaccorsi, G. A., Watson, Y., Davies, K. E., Cheung, S., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2779 · Cited by 146
Soman, N. R., Lanza, G. M., Heuser, J., Schlesinger, P. H., & Wickline, S. A. (2008) · Nano Letters · doi:10.1021/nl073290r · Cited by 140
Self-citationRiess, J. G. (1984) · Artificial Organs · doi:10.1111/j.1525-1594.1984.tb04243.x · Cited by 137
Lucken‐Ardjomande, S., Montessuit, S., & Martinou, J. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402280 · Cited by 132
Partlow, K. C., Lanza, G. M., & Wickline, S. A. (2008) · Biomaterials · doi:10.1016/j.biomaterials.2008.04.030 · Cited by 131
Self-citationImaging of Vx‐2 rabbit tumors with ανβ3‐integrin‐targeted 111In nanoparticles
Hu, G., Lijowski, M., Zhang, H., Partlow, K. C., Caruthers, S. D., Kiefer, G. E., Gulyas, G., Athey, P. S., Scott, M. J., Wickline, S. A., et al. (2007) · International Journal of Cancer · doi:10.1002/ijc.22581 · Cited by 127
Self-citationLincke, C. R., van der Bliek, A. M., Schuurhuis, G. J., der Velde-Koerts, T. V., Smit, J. J., & Borst, P. (1990) · PubMed · Cited by 120
Heuser, J. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412169 · Cited by 120
Self-citationPerfluoro Compounds as Blood Substitutes
Riess, J. G., & Blanc, M. L. (1978) · Angewandte Chemie International Edition in English · doi:10.1002/anie.197806213 · Cited by 113
Schmieder, A. H., Caruthers, S. D., Zhang, H., Williams, T. A., Robertson, J. D., Wickline, S. A., & Lanza, G. M. (2008) · The FASEB Journal · doi:10.1096/fj.08-112060 · Cited by 112
Self-citationWinter, P. M., Schmieder, A. H., Caruthers, S. D., Keene, J. L., Zhang, H., Wickline, S. A., & Lanza, G. M. (2008) · The FASEB Journal · doi:10.1096/fj.07-103929 · Cited by 105
Self-citationTu, W., Wu, C., Hsieh, H.-L., Chen, C.-Y., & Hsu, S. (2008) · Toxicon · doi:10.1016/j.toxicon.2008.06.007 · Cited by 105
Harris, T. D., Kalogeropoulos, S., Nguyen, T., Liu, S., Bartis, J., Ellars, C. E., Edwards, S., Onthank, D. C., Silva, P., Yalamanchili, P., et al. (2003) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497803322287727 · Cited by 82
Beekman, K. W., Colevas, A. D., Cooney, K. A., DiPaola, R. S., Dunn, R. L., Gross, M. E., Keller, E. T., Pienta, K. J., Ryan, C. J., Smith, D. C., et al. (2006) · Clinical Genitourinary Cancer · doi:10.3816/cgc.2006.n.012 · Cited by 80
The combined effects of antibacterial peptide cecropin A and anti-cancer agents on leukemia cells.
Hui, L., Leung, K., & Chen, H. M. (2002) · PubMed · Cited by 77
Nanoparticle pharmacokinetic profiling in vivo using magnetic resonance imaging
Neubauer, A. M., Sim, H., Winter, P. M., Caruthers, S. D., Williams, T. A., Robertson, J. D., Sept, D., Lanza, G. M., & Wickline, S. A. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21795 · Cited by 68
Self-citationAntibodies to purified bee venom proteins and peptides
Kemeny, D. M., Harries, M. G., Youlten, L. J. F., Mackenzie-Mills, M., & Lessof, M. H. (1983) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(83)90469-4 · Cited by 66
Antibodies to purified bee venom proteins and peptides
Kemeny, D. M., Mackenzie-Mills, M., Harries, M. G., Youlten, L. J. F., & Lessof, M. H. (1983) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(83)90503-1 · Cited by 63
Cholesterol Effects on BAX Pore Activation
Christenson, E. T., Merlin, S., Saito, M., & Schlesinger, P. H. (2008) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.06.037 · Cited by 49
Self-citationMartin, P. L., Jiao, Q., Cornacoff, J. B., Hall, W. C., Saville, B. A., Nemeth, J. A., Schantz, A., Mata, M., Jang, H., Fasanmade, A. A., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2623 · Cited by 42
Lanza, G. M., Abendschein, D. R., Yu, X., Winter, P. M., Karukstis, K. K., Scott, M. J., Fuhrhop, R. W., Scherrer, D. E., & Wickline, S. A. (2002) · Academic Radiology · doi:10.1016/s1076-6332(03)80220-9 · Cited by 39
Self-citationProteomic Analysis of Tumor Establishment and Growth in the B16-F10 Mouse Melanoma Model
Culp, W. D., Neal, R. E., Massey, R., Egevad, L., Pisa, P., & Garland, D. L. (2006) · Journal of Proteome Research · doi:10.1021/pr060059q · Cited by 38
Nordvall, S. L., Uhlin, T., EINARSSON, R., Johansson, S. G. O., & ÖHMAN, S. (1984) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.1984.tb02214.x · Cited by 26
Comparative studies of native and synthetic melittins
Habermann, E., & Zeuner, G. (1971) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00997294 · Cited by 25
Liver metastases from breast cancer: management of patients with significant liver dysfunction
Mano, M. S., Cassidy, J., & Canney, P. A. (2004) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2004.09.007 · Cited by 20
Cited by
Self-assembled peptide-based nanostructures: Smart nanomaterials toward targeted drug delivery
Habibi, N., Kamaly, N., Memic, A., & Shafiee, H. (2016) · Nano Today · doi:10.1016/j.nantod.2016.02.004 · Cited by 619
Nanodiamond Therapeutic Delivery Agents Mediate Enhanced Chemoresistant Tumor Treatment
Chow, E. K., Zhang, X.-Q., Chen, M., Lam, R., Robinson, E., Huang, H., Schaffer, D., Osawa, E., Goga, A., & Ho, D. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001713 · Cited by 556
Nanotheranostics for personalized medicine
Mura, S., & Couvreur, P. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.06.006 · Cited by 527
Cancer Nanomedicine: From Drug Delivery to Imaging
Chow, E. K.-H., & Ho, D. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005872 · Cited by 491
Rapoport, N., Nam, K.-H., Gupta, R., Gao, Z., Mohan, P., Payne, A., Todd, N., Liu, X., Kim, T., Shea, J., et al. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.022 · Cited by 423
Metadata
- Authors
- Soman, N. R., Baldwin, S. L., Hu, G., Marsh, J. N., Lanza, G. M., Heuser, J. E., Arbeit, J. M., Wickline, S. A., & Schlesinger, P. H.
- Venue
- Journal of Clinical Investigation
- Published
- 2009-09-01
- Volume
- 119
- Issue
- 9
- Pages
- 2830-2842
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1974134824
- Cited by
- 293
- References
- 65
- FWCI
- 8.34
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.